Quest offers the right test for the right patient at the right time
We’ve built our screening menu to correspond with age-based guidelines and recommendations from leading women’s health organizations. Our goal is to ensure your patients get the appropriate screening needed at every well-woman visit at every age.
Please select an age bracket to view the corresponding test menu:
RECOMMENDED LABORATORY SCREENING
CORRESPONDING
QUEST TEST
TEST CODE(S)
RECOMMENDED LABORATORY SCREENING
Annual chlamydia and gonorrhea testing (if sexually active)
CORRESPONDING QUEST TEST
Chlamydia/Neisseria gonorrhoeae RNA, TMA, Urogenital
TEST CODE
11363
RECOMMENDED LABORATORY SCREENING
Human immunodeficiency virus (HIV) testing (if sexually active)b
CORRESPONDING QUEST TEST
HIV-1/2 Antigen and Antibodies, Fourth Generation, with Reflexesc
TEST CODE
91431
RECOMMENDED LABORATORY SCREENING
Screening for trichomonas when risk factors are identifiedd
CORRESPONDING QUEST TEST
SureSwab® Trichomonas vaginalis RNA, Qualitative, TMA
TEST CODE
19550
Opt-in to opt-out CT/NG screening
Protect your adolescent and young adult female patients’ fertility from the long-term effects of chlamydia and gonorrhea. Commit to opt-out, an enhanced screening strategy that the CDC recommends providers consider for all female patients ages 15-24.
RECOMMENDED LABORATORY SCREENING
CORRESPONDING
QUEST TEST
TEST CODE(S)
RECOMMENDED LABORATORY SCREENING
Annual chlamydia and gonorrhea testing (under 25 and if sexually active and for older women who are at increased risk for infectiona)
CORRESPONDING QUEST TEST
Chlamydia/Neisseria gonorrhoeae RNA, TMA, Urogenital
TEST CODE
11363
RECOMMENDED LABORATORY SCREENING
Cervical Cancer Screening recommended to start at age 21:
1. In women 21–65 years of age:
Cervical cytology (Pap) alone every 3 years (Reflex to HPV if Pap is ASC-US)
2. In women 30–65 years of age:
Co-testing with Pap and HPV together every 5 years (preferred), or Pap alone every 3 years (Reflex to HPV if Pap is ASC-US)
CORRESPONDING QUEST TEST
Image-Guided Pap with Age-Based Screening Protocolse
TEST CODE
91384
CORRESPONDING QUEST TEST
Image-Guided Pap with Age-Based Screening with CT/NGe
TEST CODE
91385
CORRESPONDING QUEST TEST
Image-Guided Pap with Age-Based Screening with CT/NG, Trichomonase
TEST CODE
91386
CORRESPONDING QUEST TEST
Pap alonee
TEST CODE
See note below
RECOMMENDED LABORATORY SCREENING
Human immunodeficiency virus (HIV) testingb
CORRESPONDING QUEST TEST
HIV-1/2 Antigen and Antibodies, Fourth Generation, with Reflexesc
TEST CODE
91431
RECOMMENDED LABORATORY SCREENING
Screening for trichomonas when risk factors are identifiedd
CORRESPONDING QUEST TEST
SureSwab®, Trichomonas vaginalis RNA, Qualitative, TMA
TEST CODE
19550
Co-testing for cervical cancer with Pap and HPV together is best
A recent Quest Diagnostics Health Trends™ unprecedented 8-year data analysis of 13.6 million women between the ages of 30 and 65 across the US confirmed that more cases of cervical cancer were identified with co-testing than with HPV or Pap testing alone.
Hereditary cancer screening
For patients with a family or personal history of breast or ovarian cancer, Ashkenazi Jewish ancestry, or other potential heritable conditions, genetic testing can provide valuable information to help inform the best treatment decisions. Our hereditary cancer screening is performed on a next-generation sequencing platform in conjunction with our proprietary software to allow for the most accurate identification of disease.
RECOMMENDED LABORATORY SCREENING
CORRESPONDING
QUEST TEST
TEST CODE(S)
RECOMMENDED LABORATORY SCREENING
Annual mammography
CORRESPONDING QUEST TEST
N/A
TEST CODE
N/A
RECOMMENDED LABORATORY SCREENING
Diabetes testing every 3 years after age 45
CORRESPONDING QUEST TEST
Glucose
TEST CODE
483
CORRESPONDING QUEST TEST
Hemoglobin A1c
TEST CODE
496
CORRESPONDING QUEST TEST
Cardio IQ® Diabetes Risk Panel with Scoref
TEST CODE
92026
CORRESPONDING QUEST TEST
Diabetes Risk Panel with Score
TEST CODE
92027
CORRESPONDING QUEST TEST
Cardio IQ® Insulin Resistance Panel with Score
TEST CODE
36509
RECOMMENDED LABORATORY SCREENING
Cervical Cancer Screening
Co-testing with Pap and HPV together every 5 years (preferred)
or
Pap alone every 3 years (Reflex to HPV if Pap is ASC-US)
CORRESPONDING QUEST TEST
Image-Guided Pap with Age-Based Screening Protocolse
TEST CODE
91384
CORRESPONDING QUEST TEST
Image-Guided Pap with Age-Based Screening with CT/NGe
TEST CODE
91385
CORRESPONDING QUEST TEST
Image-Guided Pap with Age-Based Screening with CT/NG, Trichomonasee
TEST CODE
91386
CORRESPONDING QUEST TEST
Pap alonee
TEST CODE
See note below
RECOMMENDED LABORATORY SCREENING
Lipid profile assessment every 5 years beginning at age 45
CORRESPONDING QUEST TEST
Lipid Panel, Standard
TEST CODE
7600
CORRESPONDING QUEST TEST
Cardio IQ® ASCVD Risk Panel with Scoref
TEST CODE
92052
CORRESPONDING QUEST TEST
ASCVD Risk Panel with Score
TEST CODE
92053
CORRESPONDING QUEST TEST
Advanced Lipid Panel with Inflammation, Cardio IQ®
TEST CODE
94220
RECOMMENDED LABORATORY SCREENING
Thyroid-stimulating hormone testing every 5 years beginning at age 50
CORRESPONDING QUEST TEST
TSH
TEST CODE
899
CORRESPONDING QUEST TEST
TSH with Reflex to Free T4
TEST CODE
36127
CORRESPONDING QUEST TEST
Thyroid Panel with TSH
TEST CODE
7444
RECOMMENDED LABORATORY SCREENING
Colorectal cancer screening with colonoscopy every 10 years beginning at age 50 or at age 45 for African-American women (preferred); fecal immunochemical test (FIT) annually starting at age 50 as an alternative to colonoscopy
CORRESPONDING QUEST TEST
Fecal Globin by Immunochemistry (InSure®)
TEST CODE
11290
RECOMMENDED LABORATORY SCREENING
Human immunodeficiency virus (HIV) testingb
CORRESPONDING QUEST TEST
HIV-1/2 Antigen and Antibodies, Fourth Generation, with Reflexesc
TEST CODE
91431
RECOMMENDED LABORATORY SCREENING
One-time hepatitis C testing for persons born from 1945 through 1965 and unaware of their infection status (more often for high-risk patients)
CORRESPONDING QUEST TEST
Hepatitis C Antibody with Reflex to HCV, RNA, Quantitative, Real-Time PCR
TEST CODE
8472
RECOMMENDED LABORATORY SCREENING
Screening for chlamydia, gonorrhea, and trichomonas (when risk factors are identifiedd)
CORRESPONDING QUEST TEST
Chlamydia/Neisseria gonorrhoeae RNA, TMA, Urogenital
TEST CODE
11363
CORRESPONDING QUEST TEST
SureSwab®, Trichomonas vaginalis RNA, Qualitative, TMA
TEST CODE
19550
We focus on accuracy, so you can be confident in screening
Quest evaluates more Pap tests than any other lab, while still maintaining the highest of quality standards. We help ensure reliable results through an extensive algorithm of laboratory accuracy checks, and our quality control process meets or exceeds all state and federal requirements.
a Positive results may need to be reported to the authorities under applicable law. Additional assessments and recommendations may be necessary for patients with certain risk factors. For more information, visit acog.org and search for Well-Woman Recommendations.
b Healthcare providers should always follow state HIV screening requirements. For more information, visit www.cdc.gov and search for the September 22, 2006 issue of MMWR™ Recommendations and Reports.
c Reflex testing may be performed at an additional charge.
d The top risk factors are inconsistent use of condoms, multiple sex partners, and previous STI infection.
e The age-based (Smart Codes) offerings are based on ACOG recommendations and include image-guided Pap tests. The ACOG guidelines do not specify a particular type of Pap test. Both imaged and non-imaged Pap tests are acceptable under the guidelines. Non-imaged Paps, conventional Paps, as well as additional testing recommended by the guidelines, may be ordered individually and are available at Quest Diagnostics. Test codes may vary by location. Please contact your local laboratory or go to QuestDiagnostics.com/TestDirectory for more information.
f To learn more about our Cardio IQ testing, visit QuestDiagnostics.com/CardioIQ.
Test codes may vary by location. Please contact your local laboratory for more information.
References:
- Women’s Preventive Services Initiative. Recommendations for well-woman care - a well-woman chart. Updated April 2020. Accessed December 14, 2020. https://www.womenspreventivehealth.org/wellwomanchart/
- American Academy of Family Physicians. Summary of recommendations for clinical preventive services. Published July 2017. Accessed December 14, 2020. https://www.aafp.org/dam/AAFP/documents/patient_care/clinical_recommendations/cps-recommendations.pdf
- US Preventive Services Task Force. Final recommendation statement: chlamydia and gonorrhea: screening. Published September 22, 2014. Accessed December 14, 2020. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/chlamydia-and-gonorrhea-screening
- CDC. 2015 Sexually Transmitted Diseases Treatment Guidelines. Reviewed: June 4, 2015. Accessed December 14, 2020. https://www.cdc.gov/std/tg2015/default.htm
- The American College of Obstetricians and Gynecologists. Chlamydia, gonorrhea, and syphilis. Updated February 2019. Accessed December 14, 2020. https://www.acog.org/womens-health/faqs/chlamydia-gonorrhea-and-syphilis
